These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36994823)

  • 41. Epidemiological survey of patients with pustular psoriasis in the Japanese Society for Psoriasis Research from 2017 to 2020.
    Kamiya K; Ohtsuki M
    J Dermatol; 2023 Jan; 50(1):3-11. PubMed ID: 36152301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab.
    Pavia G; Gargiulo L; Spinelli F; Avagliano J; Valenti M; Borroni RG; Costanzo A; Narcisi A
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e502-e505. PubMed ID: 35224780
    [No Abstract]   [Full Text] [Related]  

  • 43. Generalized pustular psoriasis (von Zumbusch).
    Romiti R; Hirayama ALDS; Arnone M; Magalhães RF
    An Bras Dermatol; 2022; 97(1):63-74. PubMed ID: 34838431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adalimumab effectively controlled recalcitrant generalized pustular psoriasis in an adolescent.
    Callen JP; Jackson JH
    J Dermatolog Treat; 2005; 16(5-6):350-2. PubMed ID: 16428160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treating generalized pustular psoriasis: The path forward.
    Heymann WR
    J Am Acad Dermatol; 2022 Jun; 86(6):1234-1235. PubMed ID: 35381298
    [No Abstract]   [Full Text] [Related]  

  • 46. Secukinumab for the treatment of generalized pustular psoriasis: A case report.
    Li J; Gao X; Ma L; Fang Y
    Medicine (Baltimore); 2023 May; 102(18):e33693. PubMed ID: 37144985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Guillain-Barré syndrome is associated with ixekizumab in a patient with pustular psoriasis.
    Liu H; Li Q; Li Q; Li X; Dai L
    Rheumatology (Oxford); 2023 May; 62(5):e161-e163. PubMed ID: 36269188
    [No Abstract]   [Full Text] [Related]  

  • 48. Generalized pustular psoriasis of pregnancy treated with infliximab.
    Sheth N; Greenblatt DT; Acland K; Barker J; Teixeira F
    Clin Exp Dermatol; 2009 Jun; 34(4):521-2. PubMed ID: 19196309
    [No Abstract]   [Full Text] [Related]  

  • 49. IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications.
    Iznardo H; Puig L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deficiency of interleukin-36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan.
    Hsieh CY; Huang YW; Huang YH; Tsai TF
    Exp Dermatol; 2023 Aug; 32(8):1272-1278. PubMed ID: 36843341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
    Wollina U; Hansel G; Koch A; Schönlebe J; Köstler E; Haroske G
    Am J Clin Dermatol; 2008; 9(1):1-14. PubMed ID: 18092839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoinflammatory process in the pathogenesis of generalized pustular psoriasis and perspectives of its targeted therapy.
    Javor J; Buc M; Bucová M
    Epidemiol Mikrobiol Imunol; 2021; 70(3):199-207. PubMed ID: 34641694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infantile generalized pustular psoriasis with excellent response to secukinumab: A case report.
    Guevara BEK; Aquino JMRM; Diaz RBS; Contreras AIT; Jeng YC; Huang HY; Hsu CK; Pandita-Reyes BSB
    Exp Dermatol; 2023 Aug; 32(8):1296-1298. PubMed ID: 36847294
    [No Abstract]   [Full Text] [Related]  

  • 54. Generalized pustular psoriasis caused by bupropion with rapid recurrence after self-rechallenge.
    Jeng YC; Lin YC; Hsu CK; Lee JY; Lee CN
    Exp Dermatol; 2023 Aug; 32(8):1306-1307. PubMed ID: 37264715
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).
    Saeki H; Nakagawa H; Nakajo K; Ishii T; Morisaki Y; Aoki T; Cameron GS; Osuntokun OO;
    J Dermatol; 2017 Apr; 44(4):355-362. PubMed ID: 27726163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid therapeutic response of palmoplantar pustulosis under biologic treatment with guselkumab.
    Duderstadt S; Raap U; Patsinakidis N
    Dermatol Ther; 2021 Mar; 34(2):e14792. PubMed ID: 33480136
    [No Abstract]   [Full Text] [Related]  

  • 57. Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.
    Nishida M; Takeichi T; Kono M; Imanishi A; Maekawa N; Akiyama M; Fukai K
    J Dermatol; 2020 Mar; 47(3):e77-e78. PubMed ID: 31907962
    [No Abstract]   [Full Text] [Related]  

  • 58. Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease.
    Iznardo H; Puig L
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A dramatic response to a single dose of infliximab as rescue therapy in acute generalized pustular psoriasis of von Zumbusch associated with a neutrophilic cholangitis.
    Chandran NS; Chong WS
    Australas J Dermatol; 2010 Feb; 51(1):29-31. PubMed ID: 20148838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case report-Subcorneal pustular dermatosis-A great mimicker of generalized pustular psoriasis.
    Mohd Affandi A; Baharom ZF
    Exp Dermatol; 2023 Aug; 32(8):1308-1311. PubMed ID: 37000973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.